(Total Views: 92)
Posted On: 12/05/2023 1:10:47 PM
Post# of 89355

$BOLT News Article - Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu https://marketwirenews.com/news-releases/bolt...32838.html


My Twitter: WhyteStocks